nVerses Capital’s Strata Critical Medical Inc SRTA Stock Holding History

nVerses Capital’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,636	Closed	-$174K	–	317
2026 Q1	$174K	Buy	+41,636	New	+$200K	0.16%	286
2024 Q3	–	Sell	-3,400	Closed	-$11.8K	–	1026
2024 Q2	$11.8K	Buy	+3,400	New	+$11.3K	0.01%	875

Other funds holding SRTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

nVerses Capital's SRTA Position: Q2 2026 in Review

nVerses Capital sold out of Strata Critical Medical Inc (SRTA) in Q2 2026, closing a stake of 41,636 shares — an estimated $174K sold.

nVerses Capital first reported a position in SRTA in Q2 2024 and held it in 2 quarters. The position peaked at $174K in Q1 2026. 94 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

nVerses Capital reported no remaining Strata Critical Medical Inc position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 41,636 Strata Critical Medical Inc shares in Q2 2026, an estimated $174K.
nVerses Capital first reported a position in Strata Critical Medical Inc in Q2 2024 and held it in 2 quarters.
nVerses Capital's Strata Critical Medical Inc position peaked at $174K in Q1 2026.
94 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.